Citigroup Inc Cytokinetics Inc Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Citigroup Inc holds 64,898 shares of CYTK stock, worth $4.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,898

Previous 144,837 55.19%

Holding current value

$4.32 Million

Previous $4.79 Million 25.48%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$33.23 - $54.96 $2.66 Million - $4.39 Million	-79,939 Reduced 55.19%	64,898 $3.57 Million
Q2 2025 Aug 11, 2025	SELL	$29.84 - $42.92 $4.8 Million - $6.9 Million	-160,758 Reduced 52.6%	144,837 $4.79 Million
Q1 2025 May 12, 2025	BUY	$40.19 - $51.12 $420,588 - $534,970	10,465 Added 3.55%	305,595 $12.3 Million
Q4 2024 Feb 12, 2025	BUY	$46.36 - $58.62 $4.88 Million - $6.17 Million	105,285 Added 55.46%	295,130 $13.9 Million
Q3 2024 Nov 12, 2024	BUY	$51.22 - $60.16 $3 Million - $3.52 Million	58,491 Added 44.53%	189,845 $10 Million
Q2 2024 Aug 12, 2024	SELL	$47.86 - $75.05 $1.57 Million - $2.47 Million	-32,845 Reduced 20.0%	131,354 $7.12 Million
Q1 2024 May 10, 2024	BUY	$63.75 - $108.06 $333,093 - $564,613	5,225 Added 3.29%	164,199 $11.5 Million
Q4 2023 Feb 09, 2024	BUY	$26.88 - $83.49 $437,068 - $1.36 Million	16,260 Added 11.39%	158,974 $13.3 Million
Q3 2023 Nov 09, 2023	SELL	$29.46 - $36.61 $965,963 - $1.2 Million	-32,789 Reduced 18.68%	142,714 $4.2 Million
Q2 2023 Aug 10, 2023	SELL	$32.62 - $40.75 $1.64 Million - $2.05 Million	-50,356 Reduced 22.3%	175,503 $5.72 Million
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $2.31 Million - $3.17 Million	69,332 Added 44.29%	225,859 $7.95 Million
Q4 2022 Feb 09, 2023	SELL	$35.77 - $51.11 $130,953 - $187,113	-3,661 Reduced 2.29%	156,527 $7.17 Million
Q3 2022 Nov 10, 2022	BUY	$38.54 - $54.52 $929,122 - $1.31 Million	24,108 Added 17.72%	160,188 $7.76 Million
Q2 2022 Aug 10, 2022	BUY	$33.93 - $48.92 $1.37 Million - $1.98 Million	40,400 Added 42.22%	136,080 $5.35 Million
Q1 2022 May 12, 2022	SELL	$29.74 - $46.0 $2.32 Million - $3.59 Million	-77,979 Reduced 44.9%	95,680 $3.52 Million
Q4 2021 Feb 10, 2022	BUY	$34.35 - $46.38 $2.07 Million - $2.79 Million	60,249 Added 53.12%	173,659 $7.92 Million
Q3 2021 Nov 10, 2021	BUY	$18.54 - $35.74 $2.1 Million - $4.05 Million	113,410 New	113,410 $4.05 Million

Others Institutions Holding CYTK

# of Institutions

390

Shares Held

130M

Call Options Held

3.61M

Put Options Held

1.13M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $6.26B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account